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CASE REPORT

Severe Anaphylactic Reaction to
Preoperative Aspiration Prophylaxis
ABSTRACT

Muhammad Sohaib, Faraz Shafiq and Muhammad Irfan-ul-Haq

It is a case of severe anaphylactic reaction in a young female who had received aspiration prophylaxis preoperatively.
Patient required intensive care and developed severe lactic acidosis. She responded very well to fluid and phenylephrine
boluses and later on norepinephrine infusion.
Key Words: Anaphylaxis. Preoperative period. Aspiration prophylaxis. Ranitidine. H-2 receptor antagonist.

INTRODUCTION

The incidence of anaphylactic reaction to H-2 receptor
antagonists has been reported as 0.3 - 0.7%.1 These
reactions are more common in obstetric population.2
Though its routine usage as a part of aspiration
prophylaxis is not recommended for elective surgery,3
but patients having risk factor of gastro-esophageal
reflux disease, full stomach, obesity; and pregnancy
may get benefited.
The present report describes severe anaphylactic
reaction to routine prophylaxis.

CASE REPORT

A 27-year female was admitted with diagnosis of right
ovarian endometrial cyst and was scheduled for
laparoscopic ovarian cystectomy. She had no prior comorbid condition. Her preoperative assessment
including laboratory workup was unremarkable. For the
questionable history of gastro-esophageal reflux
disease, she was prescribed to have aspiration
prophylaxis two hours before coming to operative suite.
The regimen constituted syrup sodium citrate 30 ml, and
injections metoclopramide 10 mg and ranitidine 150 mg
intravenously. Soon after starting the treatment, the
patient reported difficulty in breathing and suddenly
became unconscious. On monitoring, she had unrecordable blood pressure, while heart rate was 150
beats/minute. Peripheral cyanosis was also there.
Auscultation of chest revealed bilateral harsh vesicular
breathing with SpO2 84% on 10 liters face mask. Patient
was intubated and responded well to fluid boluses and
increments of phenylephrine intravenously.
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After initial management and stabilisation of hemodynamic variables, she was shifted to intensive care
unit. Immediately after arrival in intensive care, patient
became hypotensive, developed tachycardia and
peripheral cyanosis. Patient was managed with fluid and
100 micrograms phenylephrine boluses. Meanwhile,
the arterial and CVP line were also passed and
norepinephrine was started immediately. Patient started
to improve clinically after the fluid resuscitation and
norepinephrine infusion.
Arterial blood gases at the time of arrival in ICU showed
severe metabolic/lactic acidosis with pH of 7.17 and
base deficit of -18.2 and lactate of 11.9 mmol/L. After
6 hours of ICU stay, lactate levels return to 3 and arterial
blood gases analysis showed pH 7.34, PaCO2 32.60
mmHg, PaO2 207.4 mmHg, HCO3 17.10 mEq/L, base
excess at -7.7, and SPO2 99.60% (on 0.5 FiO2). All
laboratory workups were normal except fibrin
degradation product and D-Dimers, which were raised
and deranged respectively with INR of 2.1. Further
cardiopulmonary workup was done which included
echocardiography and CT pulmonary angiography that
was absolutely normal.

The working diagnosis was severe anaphylactic
reaction, either due to the metoclopramide or ranitidine,
as both were administered intravenous, simultaneously.
After exploring the past medical history, it was found that
patient had history of minor allergic reaction to seafood.
Therefore, she was prescribed hydrocortisone 50 mg
6-hourly and chlorphenramine (8 mg) for 5 days.
Antihistamine (H2) receptor blocker was not given,
considering that it may be the cause of anaphylaxis.
Patient was extubated within 12 hours of ICU admission.
She was shifted to special care unit and then to ward
from where she was discharged to home after 3 days.
The rest of her course in the hospital was unremarkable.
Critical care team also advised her to follow allergy clinic
for further management plan, however, she did not
attend allergy clinic.
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DISCUSSION

The symptoms of allergic reactions may vary from mild
bronchospasm, flushing or hypotension, requiring
symptomatic therapy. However, in severe form, patient
may present with cardiovascular collapse, needs
aggressive treatment and organ support.4 Although it
was known that the patient developed severe reaction
associated with intravenous component of aspiration
therapy; but it was not certain whether it was due to
metoclopramide or ranitidine. Acute dystonic reactions
are the commonly associated adverse event after the
administration of metoclopramide.5 It was considered
unlikely to be the cause of anaphylaxis in this patient.
However, severe IgE mediated allergic reactions to
metoclopramide have also been reported. A young
woman with history of asthma and allergy developed
severe bronchospasm, urticarial and angioneurotic
edema after receiving metoclopramide.6

There is a strong association between the route of
administration versus the severity of symptoms. In
cases, where patients received oral ranitidine, the
severity was judged as mild;7 while anaphylaxis, due to
intravenous administration of ranitidine, was associated
with cardiovascular collapse.8 Sripriya et al. described
the symptoms of cardiovascular collapse after receiving
ranitidine in obstetric patient with difficulty in breathing,
feeble pulse, tachycardia and hypotension.9 A similar
anaphylactic reaction is reported in a parturient who
had received ranitidine as aspiration prophylaxis.10
Intravenous administration of ranitidine in patient led to
severe reaction as indicated by the need of mechanical
ventilation and significant rise in lactate level. The
pathophysiological effects of anaphylaxis result from
immune-mediated release of histamine, leukotrienes,
bradykinin, and platelet activating factor. This mediation
can cause profound vasodilation, increased vascular
permeability with transudation of fluid causing severe
hypotension. This results in decreased ventricular filling,
reduced cardiac output, and shock-like state.
Epinephrine is considered the drug of choice of treating
the vasodilatation associated with anaphylaxis. However,
in refractory conditions norepinephrine, metaraminol
and Isoproterenol can be used. This patient was given a

crystalloid bolus of 500 ml along with the increments of
phenylephrine 100 micrograms on showing peripheral
cyanosis. She responded very well to it. Meanwhile,
she also had arterial and central lines insertion.
Norepinephrine was started which was gradually
tapered off in 4 hours. After the initial management, it is
also very important to find out the cause of allergic
reaction. Patient was referred to allergy clinic, but she
did not come up and left against medical advice.
Ranitidine is routinely prescribed as pre-medication, but
anaphylactic reactions can be devastating with it.
Extreme caution and vigilance is required during intravenous administration.
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